RT @GRUPOCRONOSSEF1: Curioso artículo de ámbito general. No dejéis de echarle un ojo. A comparison of new drugs approved by the FDA, the EM…
RT @GRUPOCRONOSSEF1: Curioso artículo de ámbito general. No dejéis de echarle un ojo. A comparison of new drugs approved by the FDA, the EM…
Curioso artículo de ámbito general. No dejéis de echarle un ojo. A comparison of new drugs approved by the FDA, the EMA, and Swissmedic: an assessment of the international harmonization of drugs https://t.co/ydOfIJp5ve
RT @AlecGaffney: Where are new drugs approved first: The US or Europe? For 2/3rds of drugs, US patients get first access. Data from here:…
RT @AlecGaffney: Where are new drugs approved first: The US or Europe? For 2/3rds of drugs, US patients get first access. Data from here:…
RT @AlecGaffney: Where are new drugs approved first: The US or Europe? For 2/3rds of drugs, US patients get first access. Data from here:…
RT @AlecGaffney: Where are new drugs approved first: The US or Europe? For 2/3rds of drugs, US patients get first access. Data from here:…
RT @AlecGaffney: Where are new drugs approved first: The US or Europe? For 2/3rds of drugs, US patients get first access. Data from here:…
RT @AlecGaffney: Where are new drugs approved first: The US or Europe? For 2/3rds of drugs, US patients get first access. Data from here:…
Where are new drugs approved first: The US or Europe? For 2/3rds of drugs, US patients get first access. Data from here: https://t.co/nHEltLjZ5I Other interesting point: 76.9% of same drugs approved for different indications. https://t.co/LMK4GmJEZR
A comparison of new drugs approved by the FDA, the EMA, and Swissmedic: an assessment of the international harmonization of drugs. (ENG) https://t.co/YkgDZ4L8AO
RT @ZacharyBrennan: FDA, EMA and Swissmedic comparison on approval rates: From 2007 to 2016, 134 new drugs were approved by all three agenc…
RT @ZacharyBrennan: FDA, EMA and Swissmedic comparison on approval rates: From 2007 to 2016, 134 new drugs were approved by all three agenc…
FDA, EMA and Swissmedic comparison on approval rates: From 2007 to 2016, 134 new drugs were approved by all three agencies. Overall, 66.4% of the drugs were first approved by the FDA, 30.6% by the EMA and 3.0% by Swissmedic https://t.co/lXAo9VQ06N